Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD

Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2 Interventions:   Drug: Vildagliptin 50 mg Oral Tablet;   Drug: Metformin 1000 mg Oral Tablet;   Drug: Glimepiride 4 mg Oral Tablet Sponsor:   Damanhour University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials